NASDAQ$RXST
Rxsight Inc · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
RxSight's second quarter results for 2024 reflected a strong revenue increase driven by Light Adjustable Lens (LAL) sales and Light Delivery Devices (LDD) sales.
RxSight, Inc. reported a significant increase in revenue for the second quarter of 2024, driven by strong sales of Light Adjustable Lenses (LAL) and Light Delivery Devices (LDD). The company's revenue grew by 68% compared to the same period last year, with a notable increase in gross profit. Despite increased operating expenses, the net loss was reduced compared to the previous year.
- Reported second quarter revenue of $34.9 million, a 68% increase compared to Q2 2023.
- Sold 24,214 Light Adjustable Lenses (LAL™/LAL+™), a 92% increase in procedure volume compared to Q2 2023.
- Sold 78 Light Delivery Devices (LDD™s), a 16% increase in unit sales compared to Q2 2023, expanding the installed base to 810 LDDs.
- Increased 2024 full-year revenue and operating expense guidance.
Headline financials
Revenue & EPS history
Rxsight · Revenue · Quarterly
$34.9M
Revenue by segment
Rxsight · $11.4M total across 2 segments · Q2 2022
- LAL Revenue$5.8M—50.9%
- LDD Revenue$5.6M—49.1%
Forward guidance
The company increased its 2024 full-year revenue and operating expense guidance.
Tailwinds
- Revenue in the range of $139.0 million to $140.0 million, representing implied growth of 56% to 57% compared to 2023.
- Gross margin full-year 2024 guidance remained unchanged in the range of 68% to 70%.
Headwinds
- Operating expenses in the range of $135.0 million to $136.0 million, representing an implied increase of 30% to 31% compared to 2023.
- Including higher non-cash stock-based compensation expense guidance in the range of $29.0 million to $30.0 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q2 2024
-1.1%
Avg return
Earnings day
-2.6%
Avg return
5 days after
+2.8%
Avg return
30 days after
45%
9 / 20 earnings
Positive
+15.1%
Q3 2022
Best reaction
-16.1%
Q2 2021
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -6.6% | -21.6% | -31.1% | |
| Q4 2025 | -10.1% | -13.5% | -28.9% | |
| Q3 2025 | +8.7% | +16.3% | +46.7% | |
| Q1 2025 | -11.2% | -11.4% | +0.9% | |
| Q4 2024 | -0.8% | -7.8% | -9.1% | |
| Q3 2024 | -12.3% | -16.9% | -21.2% | |
| Q2 2024 | +14.6% | +21.5% | +29.0% | |
| Q1 2024 | +0.8% | -3.8% | -5.0% | |
| Q4 2023 | -5.8% | -3.2% | -10.9% | |
| Q3 2023 | +1.8% | +9.5% | +40.8% | |
| Q2 2023 | -1.5% | -6.3% | -1.8% | |
| Q1 2023 | +9.0% | +18.3% | +34.0% | |
| Q4 2022 | +9.7% | +4.5% | +17.9% | |
| Q3 2022 | +15.1% | +14.6% | +18.1% | |
| Q2 2022 | -2.9% | -8.3% | -13.3% | |
| Q1 2022 | -4.3% | -3.0% | +34.9% | |
| Q4 2021 | +1.4% | -3.2% | +1.8% | |
| Q3 2021 | +3.7% | -0.8% | -4.0% | |
| Q4 2020 | -16.1% | -18.4% | -21.1% | |
| Q2 2021 | -16.1% | -18.4% | -21.1% | |
| Q1 2021 | — | — | — | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro